Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.59 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18550734 | 0.89 | GAA (0.63) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL4945734 | 0.88 | GAA (0.66) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL6354623 | 0.88 | RAB9A (0.55) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL6352626 | 0.88 | L3MBTL1 (0.55) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL1085867 | 0.87 | MEN1 (0.71) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL917608 | 0.86 | MTNR1B (0.65) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL30080139 | 0.86 | MTNR1B (0.65) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL13302353 | 0.85 | MEN1 (0.69) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL9479511 | 0.84 | MTNR1B (0.68) | MEN1KMT2AMAPTMAPK1POLB | |
| SCHEMBL9479608 | 0.84 | MTNR1B (0.68) | MEN1KMT2AMAPTMAPK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1528074-B1 | NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | TOSOH CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| EP-2327739-A1 | Novel triarylamine polymer, process for its production and its use | TOSOH CORPORATION (JP) | 2011-06-01 | — | — | EP | disclosed |
| US-7608680-B2 | Triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-06 | — | — | US | disclosed |
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-06 | — | — | US | disclosed |
| US-20060241278-A1 | Novel triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2006-10-26 | — | — | US | disclosed |
| US-20060017040-A9 | Novel triarylamine polymer, process for producing the same, and use thereof | SUZUKI TAKAO | 2006-01-26 | — | — | US | disclosed |
| EP-1528074-A1 | NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Tosoh Corporation (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-20040262574-A1 | Novel triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2004-12-30 | — | — | US | disclosed |
| US-6034206-A | POLYANILINES; HEAT, CHEMICAL AND SOLVENT RESISTANCE | TOSOH CORPORATION (JP) | 2000-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282076-A1 | Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds | OCIAD1, OCIAD2, PPID | MEN1 4316/4885KMT2A 3145/4885MAPT 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.